chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: PNC
Symptoms: Bacterial test positive, Pneumococcal infection, Streptococcus test positive, Vaccination failure
Clinical narrative: This case was considered medically important. Information regarding PREVNAR 7 was received from a healthcare professional regarding a 7-year-old male patient who experienced a positive culture for streptococcal pneumoniae. The patient received the second dose on 05-Dec-2005. The patient experienced a positive culture for streptococcal pneumoniae (bacterial culture positive) (pneumococcal infection). The physician felt that the PREVNAR would have covered the strain (drug ineffective). The child is being treated for infection (unspecified) and had an ENT consult. Outcome was unknown.  No additional information was available at the time of this report.
Age: 0.17
Sex: F
Vaccine: PNC, RV5
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Electroencephalogram abnormal, Partial seizures
Clinical narrative: This case was considered medically important. Follow-up information provided outcome. Initial information regarding PREVNAR was received from a consumer then confirmed by the healthcare professional regarding a 2-month-old female patient who experienced partial seizures. At 3 months of age, the patient received the first dose on 02-Mar-2009. The patient also received a dose of ROTATEQ (Merck & Co Inc) on 02-Mar-2009. Concomitant therapy included H-B-Vax administered on 04-Feb-2009. Shortly after being administered the first dose of PREVNAR on 02-Mar-2009, the patient experienced partial seizures. The child was taken to the Emergency Room. Electrocardiogram, CT scan and blood test were done. results were unknown. The child was sent home. Since then, she has had 9 more seizures (03-Mar-2009, 04-Mar-2009, 07-Mar-2009 (2 seizures), 08-Mar-2009 and the last one on 10-Mar-2009), Electroencephalogram was done on 09-Mar-2009 which revealed an abnormality explained as the EEG showed that the child "would have had a seizure or seizures eventually". The patient recovered (2009). No additional information was available at the time of this report.
Sex: F
Vaccine: PNC
Symptoms: Blood culture positive, Chest X-ray abnormal, Pneumonia, Pneumonia pneumococcal, Streptococcus test positive
Clinical narrative: Follow-up included: medical history and test results. Information regarding PREVNAR was received from healthcare professional regarding a 3-year-old female patient who experienced pneumonia with positive blood cultures for strep pneumoniae. The patient received the fourth dose on an unspecified date. On 05-May-2009, the patient experienced pneumonia with positive blood cultures for strep pneumoniae and was hospitalized. Treatment information was not specified. Thereafter, on an unspecified date in 2009, the patient recovered. No additional information was available at the time of this report.
Sex: U
Vaccine: PNC
Symptoms: Burning sensation
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a patient who experienced burning sensation after injection with PREVENAR. The patient received a dose on an unspecified date. The patient experienced burning sensation after injection with PREVENAR. The outcome was unknown. See related case (s) US-WYE-H13774210 (adverse event, non-expedited). No additional information was available at the time of this report.
Age: 0.8
Sex: F
Vaccine: PNC
Symptoms: Pharyngitis, Pneumonia pneumococcal, Rhinorrhoea, Sinusitis, Streptococcus test positive
Clinical narrative: This case was considered medically important. Information regarding PREVNAR was received from a healthcare professional regarding an 11-month-old female patient who experienced streptococcus pneumoniae infection of sinus, throat, and nose area. At 10 months of age, the patient received the third dose on 25-Jul-2009. In Aug-2009 the patient presented to the office with a runny nose, green in color followed by a positive streptococcus pneumoniae nasal culture. The physician reported that the infection was in the sinus, throat and nose area. Treatment consisted of RIFAMPIN and OMNICEF for 10 days which was recently completed. The outcome of the events was reported as recovered. Serotype testing was not performed. No additional information was available at the time of this report.
Sex: F
Vaccine: PNC
Symptoms: Injection site erythema
Clinical narrative: Information regarding PREVNAR was received from a consumer regarding a female patient who experienced mild redness on the injection site.  The patient received a dose on an unspecified date.  The patient experienced mild redness on the injection site.  The outcome was not specified.  No additional information was available at the time of this report.
Sex: U
Vaccine: PNC
Symptoms: Injection site discomfort
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional who reported infants react in a way that suggests the injection is causing a high level of discomfort. The patient received a dose on an unspecified date. The reporter noted that infants react in a way that suggests the injection is causing a high level or discomfort. the outcome is unknown. See related case (s): US-WYE-H13405810 (adverse event, non-expedited). No additional information was available at the time of this report.
Sex: M
Vaccine: PNC
Symptoms: Blood culture positive, Body temperature increased, Drug ineffective, Pneumococcal infection, Pyrexia
Clinical narrative: This case was considered medically important. Information regarding PREVNAR 7 was received from a nurse regarding a 28-month-old male patient who experienced Streptococcal pneumoniae bacteremia - serotype 19A, and invasive pneumococcal disease Serotype 19A -  drug ineffective. The patient received the fourth dose in Feb-2008. The patient experienced Streptococcal pneumoniae bacteremia - serotype 19A in Apr-2009. The patient was taken to the Emergency Room due to a high fever. Diagostic test were performed (see test results) and the patient was admitted to the hospital. Treatments were not reported. The patient was discharged from the hospital after about one week. Streptococcal pneumoniae bacteremia and pneumococcal infection resolved. No additional information was available at the time of this report.
Sex: M
Vaccine: PNC
Symptoms: Streptococcal bacteraemia
Clinical narrative: This case was considered medically important. Information regarding PREVNAR 7 was received from a nurse regarding a 28-month-old male patient who experienced Streptococcal pneumoniae bacteremia - serotype 19A, and invasive pneumococcal disease Serotype 19A -  drug ineffective. The patient received the fourth dose in Feb-2008. The patient experienced Streptococcal pneumoniae bacteremia - serotype 19A in Apr-2009. The patient was taken to the Emergency Room due to a high fever. Diagostic test were performed (see test results) and the patient was admitted to the hospital. Treatments were not reported. The patient was discharged from the hospital after about one week. Streptococcal pneumoniae bacteremia and pneumococcal infection resolved. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Blood culture positive, Bronchiolitis, Bronchitis, Chest X-ray normal, Pneumococcal bacteraemia
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 7-month-old male patient who experienced pneumococcal bacteremia.  The patient received the third dose on 15-Jul-2009.  The patient also received the third dose of PENTACEL (Aventis-Pasteur) on 15-Jul-2009.  The patient experienced a high fever.  On 25-Aug-2009, blood culture was positive for highly resistant streptococcus pneumoniae.  Initial treatment included ROCEPHIN but changed to AUGMENTIN when blood culture came back positive.  On 27-Aug-2009, blood culture was negative.  The patient recovered.  This event either required emergency room or doctor visit.  QA results were within specifications of Lot number D46874, C87310 and D335501.  No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Pyrexia
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 7-month-old male patient who experienced pneumococcal bacteremia.  The patient received the third dose on 15-Jul-2009.  The patient also received the third dose of PENTACEL (Aventis-Pasteur) on 15-Jul-2009.  The patient experienced a high fever.  On 25-Aug-2009, blood culture was positive for highly resistant streptococcus pneumoniae.  Initial treatment included ROCEPHIN but changed to AUGMENTIN when blood culture came back positive.  On 27-Aug-2009, blood culture was negative.  The patient recovered.  This event either required emergency room or doctor visit.  QA results were within specifications of Lot number D46874, C87310 and D335501.  No additional information was available at the time of this report.
Age: 1.25
Sex: M
Vaccine: HIBV, PNC
Symptoms: Pneumococcal bacteraemia, Pneumonia pneumococcal
Clinical narrative: Follow-up information was received regarding medical history, concomitant medication, change in event onset date and patient details. Information regarding PREVNAR 7 was received from a physician regarding a 3-year-old male patient who experienced bacteremic pneumococcal pneumonia. The patient received the fourth dose on 22-Mar-2007. The patient also received the fourth dose of Haemophilus Influenzae B (manufacturer unknown) on 22-Mar-2007. The patient experienced bacteremic pneumococcal pneumonia on 12-Oct-2009. The child was hospitalized and treated with IV ROCEPHIN and recovered. The physician stated to the company representative that serotyping will be performed. No additional information was available at the time of this report.
Sex: U
Vaccine: PNC
Symptoms: Culture positive, Meningitis pneumococcal, Streptococcus test positive
Clinical narrative: This case was considered medically important. Information regarding PREVENAR was received from a healthcare professional regarding a 7-month-old patient who experienced strep pneumoniae meningitis. The patient received a dose on an unspecified date. On an unknown date, the patient developed strep pneumoniae meningitis. The child reportedly had received all required vaccinations. The outcome was not provided. No additional information was available at the time of this report.
Sex: M
Vaccine: PNC
Symptoms: Pneumonia pneumococcal
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 28-month-old male patient who experienced pneumococcal pneumonia and pneumococcal pneumonia. The patient received a dose on an unspecified date. The patient experienced pneumococcal pneumonia on 24-Jun-2009. The patient was hospitalized. Treatment included IV antibiotics. The patient recovered (2009). No additional information was available at the time of this report.
Sex: M
Vaccine: PNC
Symptoms: Meningitis pneumococcal
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a male patient who experienced pneumococcal meningitis and pneumococcal meningitis. The patient received a dose on an unspecified date. On 05-Nov-2009, the patient experienced pneumococcal meningitis and was hospitalized. Treatment included antibiotics (unspecified). The outcome was unknown. No additional information was available at the time of this report.
Sex: M
Vaccine: PNC
Symptoms: Drug ineffective, Pneumococcal bacteraemia
Clinical narrative: This case was considered medically important. Information regarding PREVENAR was received from a healthcare professional regarding a 11-month-old male patient who experienced pneumococcal bacteremia, drug ineffective. The patient received the third dose on an unspecified date. On an unspecified date, after having received 3 doses of PREVENAR, the patient experienced pneumococcal bacteremia. The reporter indicated it was unknown if the event "was caused by a vaccine or non-vaccine strain". The patient recovered on an unspecified date. No additional information was available at the time of this report.
Age: 1.15
Sex: M
Vaccine: PNC
Symptoms: Blood culture positive, Culture urine negative, Pneumococcal bacteraemia, Streptococcus test positive, White blood cell count increased
Clinical narrative: This case was considered medically important. Information regarding PREVNAR was received from a healthcare professional regarding a 3-year-old male patient who experienced pneumococcal bacteremia and pneumococcal bacteremia. At 13 months of age, the patient received the fourth dose on 02-Jan-2008. On 12-Nov-2009, the patient experienced pneumococcal bacteremia. The patient was treated with intramuscular ceftriaxone for 3 days. The patient recovered. No additional information was available at the time of this report.
Sex: M
Vaccine: PNC
Symptoms: Blood culture positive, Pneumococcal bacteraemia, Streptococcus test positive
Clinical narrative: Additional information was received providing patient demographics, medical history, product lot number and laboratory results. Information regarding PREVNAR was received from a healthcare professional regarding a 10-month-old male patient who experienced pneumococcal bacteremia. The patient received the third dose on an unspecified date. On unspecified dates, a 10-month-old patient had received three doses of PREVNAR. On an unspecified date in Nov-2009, the patient experienced pneumococcal bacteremia. The patient was hospitalized and a blood culture confirmed Streptococcus pneumoniae, serotype 7F. The patient was administered dose 4 of PREVNAR series, and was treated with antibiotics. The patient recovered on an unspecified date. No additional information was available at the time of this report.
Sex: F
Vaccine: PNC
Symptoms: Pneumococcal bacteraemia
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 5-year-old female patient who experienced pneumococcal bacteremia. The patient received a dose on an unspecified date. The patient experienced pneumococcal bacteremia on 16-Dec-2009. The patient was hospitalized and treated with unspecified IV antibiotics. The patient recovered. No additional information was available at the time of this report.
Age: 1.34
Sex: M
Vaccine: DTAP, HIBV, DTAP, HIBV
Symptoms: Decreased appetite, Depressed mood, Dyskinesia, Irritability, Listless
Clinical narrative: Fever, fussy, lethargy, headache for 48-72 hours.
Age: 1.34
Sex: M
Vaccine: DTAP, HIBV, DTAP, HIBV
Symptoms: Pyrexia, Restlessness, Screaming, Staring, Unresponsive to stimuli
Clinical narrative: Fever, fussy, lethargy, headache for 48-72 hours.
Age: 1.34
Sex: M
Vaccine: DTAP, HIBV, DTAP, HIBV
Symptoms: Headache, Irritability, Lethargy, Pyrexia
Clinical narrative: Fever, fussy, lethargy, headache for 48-72 hours.
Age: 0.21
Sex: F
Vaccine: RV5, RV5
Symptoms: Abnormal faeces, Decreased appetite, Diarrhoea haemorrhagic, Intussusception, Irritability
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N.) at the physician's office concerning an 11 week old female who on 08-APR-2010 was vaccinated with the first dose of ROTATEQ (lot number# 665159/1615Y) orally. There was no concomitant medication. On 11-APR-2010 the patient experienced lost appetite and on 12-APR-2010 she was brought back to the physician's office because she was throwing up, was sleepy and pale. That same day she also started experiencing bloody diarrhea and was taken to emergency room (kept overnight). X-ray was performed but no result was provided. It was also reported that the patient was admitted to hospital on 11-APR-2010. The patient was diagnosed with intussusception and was given barium enema. She was also treated with Air Enema. The intussusception had resolved. The patient had recovered on approximately 13-APR-2010. On 13-APR-2010, the patient was discharged. On 20-APR-2010, the patient had a follow-up visit with the physician and was doing well. The L.P.N. considered the patient's intussusception to be life-threatening. Additional information has been requested.
Age: 0.21
Sex: F
Vaccine: RV5, RV5
Symptoms: Somnolence, Vomiting
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N.) at the physician's office concerning an 11 week old female who on 08-APR-2010 was vaccinated with the first dose of ROTATEQ (lot number# 665159/1615Y) orally. There was no concomitant medication. On 11-APR-2010 the patient experienced lost appetite and on 12-APR-2010 she was brought back to the physician's office because she was throwing up, was sleepy and pale. That same day she also started experiencing bloody diarrhea and was taken to emergency room (kept overnight). X-ray was performed but no result was provided. It was also reported that the patient was admitted to hospital on 11-APR-2010. The patient was diagnosed with intussusception and was given barium enema. She was also treated with Air Enema. The intussusception had resolved. The patient had recovered on approximately 13-APR-2010. On 13-APR-2010, the patient was discharged. On 20-APR-2010, the patient had a follow-up visit with the physician and was doing well. The L.P.N. considered the patient's intussusception to be life-threatening. Additional information has been requested.
Age: 0.21
Sex: F
Vaccine: RV5, RV5
Symptoms: Barium double contrast, Barium enema, Decreased appetite, Diarrhoea haemorrhagic, Intussusception
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N.) at the physician's office concerning an 11 week old female who on 08-APR-2010 was vaccinated with the first dose of ROTATEQ (lot number# 665159/1615Y) orally. There was no concomitant medication. On 11-APR-2010 the patient experienced lost appetite and on 12-APR-2010 she was brought back to the physician's office because she was throwing up, was sleepy and pale. That same day she also started experiencing bloody diarrhea and was taken to emergency room (kept overnight). X-ray was performed but no result was provided. It was also reported that the patient was admitted to hospital on 11-APR-2010. The patient was diagnosed with intussusception and was given barium enema. She was also treated with Air Enema. The intussusception had resolved. The patient had recovered on approximately 13-APR-2010. On 13-APR-2010, the patient was discharged. On 20-APR-2010, the patient had a follow-up visit with the physician and was doing well. The L.P.N. considered the patient's intussusception to be life-threatening. Additional information has been requested.
Age: 0.21
Sex: F
Vaccine: RV5, RV5
Symptoms: Pallor, Somnolence, Vomiting, X-ray
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N.) at the physician's office concerning an 11 week old female who on 08-APR-2010 was vaccinated with the first dose of ROTATEQ (lot number# 665159/1615Y) orally. There was no concomitant medication. On 11-APR-2010 the patient experienced lost appetite and on 12-APR-2010 she was brought back to the physician's office because she was throwing up, was sleepy and pale. That same day she also started experiencing bloody diarrhea and was taken to emergency room (kept overnight). X-ray was performed but no result was provided. It was also reported that the patient was admitted to hospital on 11-APR-2010. The patient was diagnosed with intussusception and was given barium enema. She was also treated with Air Enema. The intussusception had resolved. The patient had recovered on approximately 13-APR-2010. On 13-APR-2010, the patient was discharged. On 20-APR-2010, the patient had a follow-up visit with the physician and was doing well. The L.P.N. considered the patient's intussusception to be life-threatening. Additional information has been requested.
Age: 58.0
Sex: F
Vaccine: JEV
Symptoms: Fatigue, Flank pain, Nasopharyngitis, Oropharyngeal pain, Pyuria
Clinical narrative: Sore throat resolving over 24 hours, but with increasing cold symptoms(nasal stuffiness, cough). Fatigue onset 4/26/2010 with RU flank pain, both worse by 4/27/2010.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Ear pain, Facial palsy, Hypoaesthesia, Muscle twitching
Clinical narrative: 3 days after given ZOSTAVAX, pt. c/o numbness & sharp pain in ears; twitching of eyes & burning sensation - was seen in ER. Dx: Bell's Palsy. Consult with neurologist there suggested possible (not conclusive) link to vaccine.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Pain in extremity, Pruritus, Rash, Swelling
Clinical narrative: C/o severe arm pain, swelling, itching/rash.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Pruritus, Rash
Clinical narrative: Vaccinated 15 Apr with SPV.  Past day or 2 noticed "pimple" like itchy rash on torso, arms, and legs.  Otherwise well, no fever, chills or chest pain.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 10cm by 5cm on Rt arm swollen and red.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: First Hep A shot given in Feb. 2010. The physician administered 2nd Hep A shot in error on April 23, 2010, 4 months ahead of schedule. Doctor has since said patient will need blood test in 4 months to see if additional Hep A immunization is needed to provide immunity.
Age: 19.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Dizziness, Dysstasia, Feeling abnormal, Pain in extremity, Rash
Clinical narrative: Received Gardasil and Hepatitis A.  Hour after getting right arm tremors, couldn't stand up.  States lasted all day.  Head felt empty, felt weird.  Next day better but still dizzy and hand shaking.  Able to work, complaints of bumps on chest.  4-19-10 right arm still sore.  Complaints of face breaking out.  Thinks it's Gardasil.
Age: 19.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Rash papular, Tremor
Clinical narrative: Received Gardasil and Hepatitis A.  Hour after getting right arm tremors, couldn't stand up.  States lasted all day.  Head felt empty, felt weird.  Next day better but still dizzy and hand shaking.  Able to work, complaints of bumps on chest.  4-19-10 right arm still sore.  Complaints of face breaking out.  Thinks it's Gardasil.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome
Clinical narrative: Information has been received from a physician concerning a female patient in her 80's who on 15-JAN-2008 was vaccinated with a dose of ZOSTAVAX (Merck) (route and lot # unknown). The physician reported that the patient experienced Guillain-Barre after receiving ZOSTAVAX (Merck). The patient was seen in the physician's office on 11-MAR-2008 for routine follow up. The physician also reported that the patient said she "had been in the hospital and "rehabilitation" between those visits for Guillain-Barre". At the time of the report the patient recovered on an unspecified date. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Erythema, Nausea, Pain, Swelling
Clinical narrative: Redness, pain, swelling (4 inches wide), nausea, dizziness, symptoms started the day after shot. Took ADVIL.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Erythema, Pallor, Rash macular
Clinical narrative: red, round, blanching, macular rash
Age: 1.26
Sex: M
Vaccine: DTPIPV, FLU3, IPV, MMR, VARCEL
Symptoms: Blood test, Dyskinesia, Lethargy, Pyrexia, Unresponsive to stimuli
Clinical narrative: Symptoms included laying around all day no fever during the day and at 8:22 pm he started jerking and was non responsive until emergency personnel got to my home.  (seizure)
Sex: F
Vaccine: HPV4
Symptoms: Convulsion
Clinical narrative: Information has been received from a nurse concerning a female patient who was vaccinated with "all three doses" of GARDASIL. The nurse reported that she saw on local news channel that the mother of the patient experienced seizures after receiving three doses of GARDASIL. The nurse stated that the patient's seizures were linked to GARDASIL vaccine. The patient was diagnosed with a seizure disorder. The nurse did not know the patient's recovery status and did not know the patient's identifiers. Upon internal review, seizures was considered an other important medical event. Additional information is not expected.
Age: 17.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Grand mal convulsion, Personality change, Petit mal epilepsy
Clinical narrative: Information has been received from a physician concerning a 17 year old female patient who "4 months ago", on approximately 20-DEC-2009, received the first dose of GARDASIL (Lot # not reported) from her pediatrician. The patient also received 3 other unspecified vaccines on the same day. It was reported that within 24 hours of administration of GARDASIL, the patient began experiencing seizures (petit mal and grand mal) along with personality changes. At the time of the report the patient was still experiencing petit mal seizures. The patient had been evaluated by several specialists, but no abnormal findings had been identified to the time of the report. Diagnostic laboratory tests included "blood work" (negative). Upon internal review seizures (petit mal and grand mal) were considered to be other important medical event. Additional information has been requested.
Age: 9.0
Sex: F
Vaccine: HEPA
Symptoms: Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: Severe headache later in the day, given TYLENOL, decreased appetite that evening and felt nauseous, symptoms improved in 24 hours but still felt tired.
Age: 24.0
Sex: F
Vaccine: HEP
Symptoms: Injection site induration, Injection site pruritus, No reaction on previous exposure to drug
Clinical narrative: 2nd dose; had no reaction with first dose; has a pruritic induration at injection site with this dose
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site rash
Clinical narrative: After 2 weeks from injection still have red spot on my upper arm and when I "massage" red spot it begins to throb. Hopefully the vaccination went into my body and not stayed at point of entry.
Age: 18.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal discomfort, Arthralgia, Asthenia, Oral herpes
Clinical narrative: Fever blister on lip, feeling weak, upset stomach, achy joints hurt.
Age: 18.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal discomfort, Arthralgia, Asthenia, Lip blister, Pyrexia
Clinical narrative: Fever blister on lip, feeling weak, upset stomach, achy joints hurt.
Age: 71.0
Sex: F
Vaccine: HEPA, VARZOS
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Itchy red rash all over torso & under arms.  Appeared day after injection - applied cortisone cream lasted 7 days = Still getting itchy episodes on chest & under rib cage.
Age: 8.0
Sex: F
Vaccine: HEPA, TYP, YF
Symptoms: Pruritus, Rash erythematous, Rash maculo-papular
Clinical narrative: 4/15/10 -night/bed time. Some red spots on legs (upper thighs). By Sunday, spots were on thighs, buttocks, trunk, belly & chest. Raised slightly, red by 4/20/10 progressed to arms & face. Itchy. Sunday started BENADRYL. By Tuesday resolving -Wed (4/21) faint, less itching.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Feeling hot, Local swelling, Pain
Clinical narrative: Local swelling, erythema warmth, pain x 1 wk.
Age: 63.0
Sex: F
Vaccine: FLU(H1N1), PPV
Symptoms: Inappropriate schedule of drug administration, Joint range of motion decreased, Oedema peripheral, Pain in extremity
Clinical narrative: Aching arm with swelling and limitation of movement. Pt. using TYLENOL q 4 hours for pain and cold compress (for swelling). Pt had previous PNEUMOVAX post surgery 02/02/10 and did not remember receiving it. Husband reminded her after PHN gave imm. this date - 4/22/10.
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMR, VARCEL
Symptoms: Injection site erosion, Injection site erythema
Clinical narrative: 5" x 5" area of erythema on proximal anterior left thigh surrounding injection site and small 2 cm excoriation. BENADRYL PRN.
Age: 21.0
Sex: F
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: None stated
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Patient was given MMR vaccine 3-8-10. Was to return 2 wks for KINRIX and then 1 month for Varicella. When returned on 3-22-10 was given Varicella when it should have been KINRIX, no adverse effect. Other than vaccine being given too early, there was no adverse effect.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness & swelling on R arm noted greater or equal to ab 24 hours after vaccination. Symptoms resolved after 48 hours.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Convulsion, Electroencephalogram abnormal, Nasal congestion, Nuclear magnetic resonance imaging abnormal, Pyrexia
Clinical narrative: Received H1N1 0.5 ml (2nd dose) on 12/28/09. Onset fever (101.9) on 12/30/09 nasal congestion. Hx head drop spells x 1 on 1/3/10 and 2 spells 1/4 am. During EEG at neurology on 1/8/10 had spells and EEG findings c/w seizures. Started on KEPPRA. Prior hx febrile sz 8/15/07 and unprovoked sz 4/28/09. MRI & EEG on 7/09 wnl.
Age: 0.22
Sex: F
Vaccine: DTAPIPVHIB, HEP, IPV, PNC, RV5
Symptoms: Incorrect dose administered
Clinical narrative: Additional dose of POLIO inadvertently administered at time of 2 mo. old immunization.
Age: 42.0
Sex: F
Vaccine: HIBV, PPV
Symptoms: Cellulitis
Clinical narrative: Cellulitis of arm.
Age: 0.56
Sex: M
Vaccine: PNC
Symptoms: Blood culture positive, Cough, Pneumonia streptococcal, Pyrexia, Streptococcus test positive
Clinical narrative: This 16 m.o. boy had onset of cough, fever on 4-14-10.  Fever reached 105, and child brought to Med. Center ED on 4-17-10 and admitted.  Discharged 4-19-10.  Diagnosed with positive Strep Pneumo Blood Cx.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, PNC, VARCEL
Symptoms: Injection site swelling, Pallor
Clinical narrative: 3.5x5 mm raised, blanche, ( R ) thigh.
Age: 26.0
Sex: F
Vaccine: HPV2
Symptoms: Dyspnoea, Wheezing
Clinical narrative: Pt called doctor's office today. C/o "trouble breathing & wheezing on day of injections, that evening. Feels better today.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Blister, Erythema, Rash papular, Skin lesion
Clinical narrative: Developed red papule on left lower eyelid and within one hour developed multiple. 10-12 red papules on nape of  neck, left thigh, right thigh, abdomen. Left and right upper arm lesion 1 mm clear almost vesicle like center surrounded by 2-3 mm red base.
Age: 56.0
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Oedema peripheral, Pain in extremity, Pyrexia, Skin warm
Clinical narrative: Started off with sore arm. Then redness and warmth. Thur morning 4/23 fever with arm swollen and hot. By evening arm welted down entire upper arm. Fever increased. Fri, Sat Sun continued icing and took ibuprofen every 6 hrs.  By Sun/Mon started to ease up on symptoms. Today continues to be slightly red, slight warmth and improving.
Age: 56.0
Sex: F
Vaccine: DTAP
Symptoms: Urticaria
Clinical narrative: Started off with sore arm. Then redness and warmth. Thur morning 4/23 fever with arm swollen and hot. By evening arm welted down entire upper arm. Fever increased. Fri, Sat Sun continued icing and took ibuprofen every 6 hrs.  By Sun/Mon started to ease up on symptoms. Today continues to be slightly red, slight warmth and improving.
Age: 36.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Haematoma, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient with severe swelling, erythema, and pain to right deltoid area. Palpable hematoma.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Oedema peripheral, Pain, Urticaria
Clinical narrative: Local reaction - red welt over injection sight with leg swelling. TYLENOL was taken for pain & ice used to reduce swelling in leg.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Pt had DTaP administered on 4/19/10. Pt came in with a 9 x 6.75 cm reaction with warmth and redness to (R) deltoid.
Age: 3.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Redness at vaccine site - ( R ) thigh. ? local Rx. ~ area warm rxn pos about 3x4 cm but about 2 cm to side of injection site.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Antibody test negative, Antineutrophil cytoplasmic antibody positive, Antinuclear antibody, Antinuclear antibody positive, Antiphospholipid antibodies negative
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Bacteraemia, Cholelithiasis, Cryoglobulins present, Escherichia urinary tract infection, Fibrin degradation products
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Gastroenteritis Escherichia coli, Haptoglobin increased, Headache, Hepatitis B core antigen positive, Hepatitis B surface antigen negative
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Hepatitis B surface antigen positive, Hepatitis C antibody positive, Hepatitis C virus test positive, Leukopenia, Nausea
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Pain, Palpitations, Pruritus, Pyrexia, Rash erythematous
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Rash generalised, Skin discolouration, Smooth muscle antibody positive, Splenomegaly, Staphylococcal infection
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 44.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Tenderness, Thrombosis, Vasculitis, Vomiting
Clinical narrative: Patient is a 44yo female patient with h/o HTN, asthma. Patient reports that she initially developed a rash over her abdomen 6 days after receiving the H1N1 live attenuated nasal flu vaccine on 11/14/09. The rash began as red to purple spots and patches over her abdomen that were itchy. She developed concomitant nausea, vomiting and headaches, unaccompanied by fever. The rash subsequently spread to involve her face, arms, legs, and most recently the buttocks area. Patient presented to hospital for evaluation on 11/21/09. There she was found to have an E Coli UTI and bacteremia -with 3 out of 4 blood cultures positive for coag negative staph-. Patient was placed on vanc, zosyn, and LEVAQUIN for treatment. A skin biopsy was performed from the left lower quadrant of the abdomen. The biopsy was taken on 11/24/09 and showed "Extensive acute vasculitis and focal thrombosis." Further workup included C3 and C4 levels -normal-, ANCA levels -+, 1:320 with speckled pattern echocardiogram -normal-, and abdominal ultrasound, which showed gallbladder sludge and splenomegaly. Of note patient was found to be Hep C antibody positive and HIV negative. Pt was also found to be slightly leukopenic with WBC of 5 and was given NEUPOGEN. Rash continued to spread and became tender to palpation. Patient denied taking any medications regularly or taking any meds prior to onset of rash. Denies known drug allergies. Denies fever, cough, chills, shortness of breath, pain or burning on urination, urgency, joint pains or current headaches. It is unknown whether pt's rash represented ANCA-associated vasculitis secondary to vaccine or cyrofibrinogenemia related to patient's previously undiagnosed hepatitis C on other vasculitis of unknown etiology. Pt responded well after treatment with high dose IV steroids and then transition to high dose PO steroids. Had to be readmitted to hospital after initial admission due to uncontrolled pain and for wound care. Eventually healed with significant scarring.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: Pt came to office today 4/27/2010 for follow up of (L) upper arm cellulitis from PNEUMOVAX injection. Treated with Azithromycin 250 mg (Z Pak). Reaction 10-12cm area.
Age: 79.0
Sex: M
Vaccine: TDAP
Symptoms: Wrong drug administered
Clinical narrative: TDAP given instead of TD at community health fair. Patient reported on 4-26-2010 that he had no adverse reaction to shot at all. He stated that his arm was not sore or swollen at all.
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Chills, Decreased appetite, Diarrhoea, Dizziness, Headache
Clinical narrative: Vomited x 2 today, dizziness x 2 since yesterday, chills, loss of appetite, headache x 1 day, loose stool x 1 today. Patient has been drinking water.
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Vomiting
Clinical narrative: Vomited x 2 today, dizziness x 2 since yesterday, chills, loss of appetite, headache x 1 day, loose stool x 1 today. Patient has been drinking water.